Cargando…
TRAIL Receptor Signaling Regulation of Chemosensitivity In Vivo but Not In Vitro
BACKGROUND: Signaling by Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) and Fas ligand (FasL) has been proposed to contribute to the chemosensitivity of tumor cells treated with various other anti-cancer agents. However, the importance of these effects and whether there are differen...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3021504/ https://www.ncbi.nlm.nih.gov/pubmed/21264287 http://dx.doi.org/10.1371/journal.pone.0014527 |